MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$67,384K
Net Income
$2,154K
Net Profit Margin
3.20%
EPS
$0.03
Unit: Thousand (K) dollars
Revenue Breakdown
Logistics
Clinical
Revenue Breakdown
Logistics
Other Clinical
Transplant Clinical
Revenue Breakdown
Cost of revenue
Gross profit
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
Revenue
67,384
53,245*
49,298
Cost of revenue
53,267
42,963*
37,684
Software development
-
-
453
Gross profit
14,117
10,282*
-
General and administrative
-
-
16,301
Selling, general and administrative
15,605
15,118*
-
Selling and marketing
-
-
482
Amortization of intangible assets
1,486
651*
-
Total operating expenses
17,091
15,769*
54,920
Operating loss from continuing operations
-2,974
-5,487*
-5,622
Interest income, net
473
860*
1,127
Change in fair value of warrant liabilities
-1,459
-4,179*
-33
Change in fair value of assets and other liabilities
-3,444
259*
-
Realized gain from sales of short-term investments
-
9,612*
-5,195
Total other non-operating income
5,376
14,392*
-4,035
Net gain from discontinued operations
-248
-139,806*
67,073
Net income (gain)
2,154
-130,901
57,416
Basic EPS
0.03
-1.602
0.7
Diluted EPS
0.03
-1.602
0.7
Basic Average Shares
85,322,941
81,730,033
82,454,657
Diluted Average Shares
90,168,853
81,730,033
82,454,657
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
Cost of revenue
$38,434K
Gross profit
$9,165K
Cost of revenue
$14,833K
Gross profit
$4,952K
Change in fair value of
assets and other...
-$3,444K
Change in fair value of
warrant liabilities
-$1,459K
Interest income, net
$473K
Logistics
$47,599K
Clinical
$19,785K
Total other
non-operating income
$5,376K
Revenue
$67,384K
Net income (gain)
$2,154K
Operating loss from
continuing operations
-$2,974K
Net gain from
discontinued operations
-$248K
Gross profit
$14,117K
Cost of revenue
$53,267K
Total operating
expenses
$17,091K
Selling, general and
administrative
$15,605K
Amortization of intangible
assets
$1,486K
Buy us a coffee
Strata Critical Medical, Inc. (SRTAW)
Strata Critical Medical, Inc. (SRTAW)